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In  previous publications  (1-3)  there has been described an antagonism between 
one routine strain (SK) and three simian strains (SK, Aycock, RMV) of poliomyelitis 
virus.  This antagonism was  shown  by the  survival of rkesus  monkeys which had 
received mouse  virus  prior  to  or  following  infection  with  monkey  virus;  on  the 
other hand,  monkey  virus  failed  to  save  mice  from  murine  infection.  The  pro- 
tection which occurred under well defined experimental conditions differed from the 
classical processes of immunity but resembled a  phenomenon which is now generally 
termed "interference." 
Certain variables were recognized as determining success or failure in the operation 
of this interference effect, all of them connected essentially with quantitative relation- 
ships existing between the opposing viral agents in the field.  For instance, in experi- 
ments  in which  the two  viruses were  injected intracerebrally in  form  of mixtures, 
a  definite ratio between the infecting amounts of simian or murine virus had to be 
observed  in  order  to  secure  protection.  When  both  viruses  were  introduced  by 
separate routes, i.e. simian virus intracerebrally and murine virus peripherally, much 
larger amounts of the latter were necessary to check the infection; moreover, apart 
from providing adequate initial dosage, the administration of murine virus had to 
be maintained by multiple injections.  With properly balanced proportions between 
simian and murine virus, the final measure of success in preventing or modifying the 
development of paralysis depended on the length of the interval that separated the 
introduction of both viruses.  Thus, the disease could be prevented with considerable 
regularity in  monkeys which  had  received mouse  virus shortly before injection of 
monkey virus.  Definite protective action was still demonstrable when mouse virus 
was  injected  on  the  day  of  infection  with  monkey  virus.  This  action,  however, 
diminished gradually as the administration of mouse virus was successively delayed 
during the incubation period of the disease, reaching its endpoint of efficiency shortly 
before transition of the preparalytic period into the paralytic stage. 
The  foregoing  observations  left  no  doubt  that  the  interfering  effect  produced 
by murine virus depended, for its successful operation, upon the presence of critical 
thresholds of concentration of the infectious agent.  Moreover, it seemed as if the 
resulting protection was  achieved through  an  engagement  between  the  susceptible 
cell  and  the  actively propagating  virus  particle.  For  destruction  of  potency  by 
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heat, as determined by mouse test, also destroyed the power of the murine virus to 
interfere in monkeys.  However, exposure to ultraviolet light, while bringing about 
marked reduction in pathogenicity, preserved some protective action, in fact more 
than  could be accounted for on the basis  of the surviving residue  of active virus. 
The question therefore arose whether interfering and infectious effect were one and the 
same, or whether there was present in the viral material another non-infectious agent, 
attached  to  the  virus  particle  or free,  which  was  responsible  for the  interference 
phenomenon.  In  the  absence  of further  knowledge,  this  question  had  to  remain 
unanswered.  Another unsolved problem related  to the extent of specificity of the 
process.  In this respect our observations were limited  to establishing  that neither 
a neurotropic strain of herpes virus nor normal mouse brain or normal tissue culture 
medium afforded any protection. 
The above review, which outlines the known facts, also discloses the limita- 
tions of our knowledge.  In the present paper there will be described further 
studies,  undertaken  in an effort to widen  the  scope of such knowledge along 
what promised  to be  the  most fruitful  lines  of investigation.  These  studies 
are concerned with attempts  to determine: first, whether fractionation of SK 
murine virus by physical or chemical methods would yield any more precise 
information  on the  nature  of the  interfering  principle  in viral  mouse  brains 
or  tissue  culture  preparations;  second,  whether  other  viruses  belonging  to 
the poliomyelitis group (4) were capable of interfering with simian virus under 
comparable  experimental  conditions.  The  viruses  chosen  for  the  latter 
purpose were,  (a)  another artificially adapted  murine strain  (MM)  of human 
poliomyelitis virus  (5)  and,  (b)  one murine  strain  (GDVII)  of naturally  oc- 
curring Theiler  mouse encephalomyelitis virus  (6). 
EXPEI~/M~.NTAL 
The Effect of Various Physical Agencies on the Interfering Ability 
of SK Murine Virus 
In the first group of experiments  SK murine virus was exposed  to various 
physical agencies in an attempt to dissociate, if possible,  the interfering prin- 
ciple from the virus particle itself. 
The procedures used were those of ultracentrifugation,  ultrafiltration, and dialysis.  Murine 
virus (0.5 cc. of I0 per cent mouse brain suspension or tissue culture fluid), treated by the 
above methods, was mixed in vitro with simian virus (0.5 cc. of 1 or 2 per cent monkey cord 
suspension-Aycock  strain).  Immediately  after their preparation  the mixtures were injected 
intracerebrally  into rhesus monkeys.  Control animals which had received untreated murine 
virus alone, untreated murine virus in combination with simian virus, or simian virus alone 
accompanied these tests.  Table I lists the results obtained. 
The  data  presented  in  Table  I  permit  a  reasonable  interpretation  of  the 
findings.  Thus,  the  supernatant  fluid  of  a  viral  mouse  brain  suspension, 
which after ultracentrifugation  for 40 minutes at 36,000 R.P.M. still contained 
appreciable  amounts  of active  virus,  apparently  protected  one  monkey but CLAUS W.  ~UNGEBLUT  277 
not another.  On the other hand, the filtrate of virus-containing tissue culture 
fluid  obtained  by  passage  through  a  10  mg  collodion  membrane  possessed 
no active virus and did not exhibit any interfering capacity in the one monkey 
tested.  A  virus brain suspension,  which after prolonged dialysis (48  hours.) 
through  a  cellophane  bag  had  lost  only  little  of  its  potency,  interfered  ef- 
fectively in  4  of  6  monkeys,  whereas  the  surrounding  fluid,  which  was  free 
TABLE I 
Interference between  SK Murine Virus, Exposed to Various Physical A gencies, and Simian Virus 
Physical 
Agencies 
Ultracentrif- 
ugafion 
Ultrafiltration 
Dialysis 
Controls 
Intracerebral  injection  of virus mixtures 
Murine virus  (SK) 
Supernatant  of  ultracentrifuged [ 
mouse  brain  virus  0.5  cc.  1:101 
Result 
Ultrafiltrate of tissue culture virus 
0.5 cc. undiluted 
Dialyzed mouse brain virus 0.5 cc. 
1:10 
Dialysate  of  mouse  brain  virus 
0.5 cc. 1:10 
Untreated mouse brain virus 0.5 cc. 
1:10 
Untreated tissue culture virus 0.5 cc. 
undiluted 
Untreated mouse brain virus 0.5 cc. 
1:10 
Untreated tissue culture virus 0.5 cc. 
undiluted 
Simian virus  No pa- 
(Aycock)  ralysis 
0.5 cc.  1:50  1 
0.5 cc.  1:100  1  1  0 
0.5 cc.  1:50  6  2  4 
0.5 cc.  1:50  6  6  0 
0.5 cc.  1:50  3  1  2 
0.5 cc.  1:100  12  3  9 
0.5 cc.  1:50  10  10  0 
0.5 cc.  1:100  5  5  0 
--  3  0  3 
--  1  0  1 
from active virus, failed to afford any protection to a  similar group of 6 mon- 
keys.  Untreated  viral  mouse  brain  suspension  gave  positive  interference 
in  2  of 3  monkeys and untreated viral tissue culture preparations prevented 
paralysis in 9  monkeys of a  group of 12  animals so tested.  All of 15  control 
monkeys  which  had  received  only  the  test  dose  of  simian virus  succumbed 
to  prostrating  paralysis.  None  of  4  control  monkeys  which  had  received 
the test dose of untreated murine virus alone showed any ill effects. 
The  outcome  of  these  experiments  indicates  that  routine  virus  contained 
no  agent,  capable  of  interfering  with  simian  virus  in  the  quantities  tested, 
which  could  be  dissociated from  the  viral  material  by  means  of  the  ultra- 278  RODENT  POLIOMYELITIS.  VI 
filtration  or dialysis employed as above described,  processes which obviously 
separated  the  infectious  unit  from  its  menstruum.  The  irregular  results 
obtained  with  virus  following ultracentrlfugation  are  to be  explained,  in  all 
probability, by the fact that sedimentation  had failed to bring about a  sharp 
division between infectious and non-infectious material. 
The Effect of Various Chemical Procedures on the Interfering Ability 
of SK Murine Virus 
In  the  following  experiments  SK  murine  virus  was  subjected  to  various 
chemical  procedures  in  order  to  determine  whether  such  treatment  would 
accomplish  any  separation  between  the  interfering  principle  in  the  viral 
material and the factor which causes pathogenicity in mice. 
The methods employed were (a) ether extraction,  (b) precipitation  by sodium sulfate,  (c) 
exposure to attenuating or virucidal agents such as phenol, formalin, and specific anti-murine 
immune serum.  Ether extraction  was chosen since with  this  procedure  a viral brain sus- 
pension can be divided into two fractions, one ether-insoluble which carries ail of the original 
virus activity,  another  ether-soluble which is practically  free from virus  and contains  the 
bulk of the inert fatty material  (7).  Precipitation  with sodium sulfate was used because it 
permitted  the elimination of large amounts  of virus with the precipitate  and afforded an 
opportunity for removing most of the salt from the filtrate by crystallization  in the ice box 
(8).  Treatment with phenol, formalin, or immune serum was decided upon because these 
substances  will bring  about different degrees of virus attenuation or destruction,  yielding 
preparations  which function  as efficient vaccines in the case of certain  other viruses.  In 
examining the various products for their interfering capacity in rhesus monkeys, the mixture 
test  was  used  as  previously  described.  Control  animals  which  received  only  the  test 
dose of simian virus dccompanied these experiments.  The results will be found in Table II. 
It appears from Table II that ether-extracted mouse brain virus which had 
lost  none  of its  infectiousness  for  mice,  protected  2  monkeys,  whereas  the 
ether-soluble fraction, which contained only traces of virus, had no protective 
power.  The  supernatant  fluid  resulting  after  precipitation  of  viral  mouse 
brain suspensions  or tissue culture fluid by sodium sulfate,  failed to interfere 
in 4  of 5 monkeys even though it still carried some active virus.  Phenolized 
mouse brain  virus  (0.25  per  cent phenol)  which  contained  residual  amounts 
of active virus  likewise  proved  ineffective  for interference.  The  results  ob- 
tained  with  formalinized  mouse  brain  virus  show  that  one preparation  (0.1 
per  cent formalin),  which appeared  entirely  free from active virus,  failed  to 
interfere whereas another preparation  (0.02 per cent formalin), in which some 
virus  had  escaped  destruction  (intracerebrally  10-1;  intraperitoneally  nega- 
tive),  apparently  protected  1  of 3  monkeys.  A  last  preparation,  consisting 
of  mouse  brain  virus  in  neutral  mixture  with  anti-murine  immune  serum, 
interfered  effectively in  the  one  monkey in  which  it  was  tested.  All  of  10 
control animals succumbed to prostrating paralysis. 
The  data  tend  to  show,  in  general,  that  chemical action  which  preserves CLAUS  W.  JUNGEBLUT  279 
infectiousness  also  preserves  the  interfering  ability  while  chemical  action 
which  destroys  infectiousness  usually  also  destroys  the  protective  action  of 
the virus.  It  is therefore  evident  that  none  of  the  chemical procedures  em- 
ployed  (with  the  possible  exception  of  the  immunological)  permitted  a  clear 
distinction  between pathogenic  and  interfering  function  of murine  virus. 
TABLE II 
Interference between SK Murine Virus, Treated by Various Chemical Procedures, and 
Simian Virus 
Intracerebral injection of virus mixtures 
Chemical 
procedures  Simian virus 
Murine virus SK  (Aycock) 
Ether  extrac-  Ether extracted mouse brain virus  0.5 cc.  1:50 
tion  0.5 cc. 1 : 10 
Ether  soluble  material  0.5  cc.  ' ..... 
1:10 
Precipitation 
by  sodium 
sulfate 
Germicidal 
action 
Anti-murine 
immune 
serum 
Controls 
Supernatant after precipitation of 
mouse brain virus 0.5 cc. 1 : 10 
Supernatant  after  precipitation 
of tissue  culture  virus 0.5  cc. 
undiluted 
Phenolized (0.25 per cent) mouse 
brain virus 0.5 cc. 1 : 10 
Formaiinized (0.1 per cent) mouse 
brain virus 0.5 cc. 1 : 10 
Formalinized  (0.02  per  cent) 
mouse brain virus 0.5 cc. 1 : 10 
SK  anti-murine  horse  serum  in 
neutral  mixture  with  mouse 
brain virus 0.5 cc. 1 : 10 
B 
0.5 cc.  1:50 
0.5 cc.  1:100 
Result  No. of 
lllon- 
keys  Paral- !  No pa- 
ysis  i  ralysis 
2  0  2 
1  I  0 
2  2  0 
3  2  1 
0.5 cc.  1:50  1  1  0 
0.5 cc.  1:50  1  1  0 
"  "  "  3  2  1 
0.5 cc.  1:50  1  0  1 
J 
I  0.5cc.  1:50  9  9  0 
0.5 cc.  1:100  1  1  0 
Some  of  the  preparations  of  modified  SK  murine  virus  which  had  been 
examined  for  their  power  to  interfere  in  mixture  tests  with  simian  polio- 
myelitis virus, were further investigated for their capacity to prevent or modify 
the experimental disease. 
In one series, monkeys received the various preparations by multiple injections given prior 
to and resumed shortly after infection with simian poliomyelitis virus.  In another series of 
monkeys these injections were commenced on the day of infection and thereafter maintained, 
at intervals, for a period of about 2 weeks.  In order to provide a basis for comparison of the 280  RODENT  POLIOMYELITIS.  VI 
relative degrees of efficacy, a number of monkeys were included which received unmodified 
murine virus before and after infection with simian virus.  The experimental conditions were 
further varied by administering murine virus in different dosage and by different peripheral 
TABLE III 
Interference between SK Murine  Virus,  Treated by  Various Chemical Procedures, and 
Simian Virus in Experiments for the Prevention of Infection 
No. 
of 
mon- 
keys 
14 
Mode of attempt to prevent infection  Infection with monkey virus 
(last dose of murine virus given 1 day  (Aycock strain) 
before infection) 
Preparation  Result 
Untreated mu- 
rine virus 
Ether extracted 
murine virus 
Formalinized 
murine virus 
Murine virus- 
anti-murine 
serum  mix- 
ture 
Controls 
Total 
dosage 
No. of injections of  10 per  Route of  Dose 
murine virus  cent  adminis-  (intra-  Corn- 
brain  tration  cerebral)  plete  Partial  No 
suspen-  paral-  paral-  paral- 
ston  ysis  ysis  ysis 
cc. 
6  injections before  in-  54-64  Subcuta-  0.5 cc.  1:50  2*  0  4 
fection and 2-4 in-  neous 
jections after infec- 
tion 
"  "  "  Intravenous  "  "  "  2*  1  3 
"  "  8  "  "  "  "  2  0  0 
6 injections before in-  54-60  Subcuta-  0.5 cc.  1:50 
fection  and  3-4  in-  neous 
jections  after  infec- 
tion 
"  "  54 
3  injections before in-  30-36 
fection  and  2-3  in- 
jections  after  infec- 
tion 
3 injections before in-  36 
fection  and  3  injec- 
jections  after  infec- 
tion 
1  0  2 
Intravenous  "  "  "  2  1~  0 
Intravenous  0.5 cc.  1:50  6  1  1 
Intravenous  0.5 cc.  1:50  2  0  1 
--  0.5 cc.  1:50  12  2  0 
* The incubation  period of these 4 animals was unusually  long, i.e. 16, 25, 19, 28 days, as 
compared with an average incubation  period of 7 to 12 days for the controls. 
This monkey showed, 1 day after infection with simian virus, a weakness of all extremi- 
ties  which progressed  to  generalized paresis  and  then remained  stationary.  The  early 
atypical  symptoms  in  this  animal were probably  caused  by the  cumulative  action  of 
murine  virus. 
routes.  Control monkeys injected with only the test dose of simian virus (0.5 cc. Aycock 
virus 1 : 50 intracerebrally)  accompanied both sets of experiments.  The results are shown in 
Tables III and IV. 
It will be seen from Table III that in a  group  of  12  monkeys which had 
received  large  doses  of  unmodified  mouse  brain  virus,  7  escaped  without 
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ether-extracted  mouse  brain  virus,  showed  only  2  non-paralytic  survivors. 
Equally unsatisfactory was  the  use  of  serum-virus  mixtures,  since  2  of  3 
monkeys so  treated  developed paralysis.  No  conclusive  evidence  of  inter- 
ference was obtained with  formalinized mouse brain virus which left  7 of 8 
TABLE IV 
Interference between SK  Murine  Virus,  Treated by  Various Chemical Procedures, and 
Simian Virus in Experiments to Modify the Infectious Process 
No. 
m°ofn.  Preparation 
keys 
3  Untreated mu- 
rine virus 
3 
3  Ether extracted 
murine virus 
3  .  (t 
3  Formalinized 
murlne virus 
7  Controls 
Mode of attempt to modify the disease 
Total 
dosage 
No. of injections of  (10 per  cent 
murine virus  brain 
suspen- 
sion) 
6 injections  for first  3  51-54 
days; thereafter in- 
jections  continued 
on alternating days 
"  "  60 
I  injection only  on  0.5 
day of infection 
6 injections  for first  3  48-60 
days; thereafter in- 
jections  continued 
on alternating days 
"  "  8-10 
Infection with monkey virus 
(Aycock strain) 
Result 
Doge 
Route of  (intra-  Corn-  Partial ]  No 
injection  cerebral)  plete  paral-  [ paral- 
paral-  ysis  ysis 
__  ySlS 
Subcuta-  0.5 cc.  1:50  1  1  1 
neous 
Intravenous  ,,  ,,  ,  0  0  2 
Intraspinal  "  "  "  1  1  1 
Subcuta-  0.5 co.  1:50  1  1  1 
neous 
Intravenous  "  "  "  1  1"  1 
"  "  "  "  1  2  0 
6 injections for first 3  65-81  Intravenous  0.5 cc  1:50  3  0  0 
days;  thereafter  in- 
jections  continued 
on alternating days 
--  --  --  [  0.5  cc.  1:50  6  1  0  ) 
* This monkey showed 2 days after infection with simian virus, spastic pareses of all ex- 
tremities which were followed  by convulsive attacks.  The animal was killed on the 6th day. 
The autopsy revealed lesions consistent with poliomyelities.  The early atypical symptoms 
in this animal were probably caused by the cumulative action of murine virus. 
monkeys unprotected.  A  similar  trend  is  revealed by the  results  shown in 
Table IV.  In a  group of 5 monkeys, treated with  large doses of unmodified 
mouse brain virus, 3  animals  survived without paralysis.  Another group of 
6  monkeys,  treated  with  large  doses  of  ether-extracted  mouse  brain  virus, 
showed  only  2  non-paralytic  survivors.  No  protection  was  obtained  with 
3  monkeys which  had  received  formalinized  mouse  brain  virus.  All  of  21 
control animals,  accompanying  both  sets  of experiments,  succumbed  to  the 
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As might have been expected, the over-all protection obtained when murine 
and simian virus are introduced by separate channels is on a somewhat lower 
level than the protection obtained when both viruses are  injected  together 
in the form of a mixture; except for this reservation, the results obtained with 
both methods are  in  general agreement.  In  other words,  it appears  again 
that murine virus, which after chemical treatment had retained some viability, 
had also retained various degrees of its power to interfere with simian virus; 
by contrast, murine virus which had been fully inactivated had also completely 
lost  its  interfering  capacity.  Apart  from  these  findings,  the  experiments 
demonstrate anew  the  significance of utilizing optimum dosage and optimal 
routes of administration if effective interference is to take place.  Thus, no 
protection  was  obtainable when monkeys received only small quantities  of 
murine  virus in  either  prophylactic  or  therapeutic  tests.  Moreover,  the 
subcutaneous route seemed superior to the intravenous route in prophylactic 
tests, whereas the reverse was true for therapeutic experiments.  An explana- 
tion  seems  to  lie  in  the  necessity for providing working conditions which, 
on the one hand, decelerate the elimination, and, on the other, accelerate the 
distribution of murine virus in a manner most conducive to effectively blocking 
a majority of the susceptible cells. 
The Effect of Ultraviolet Irradiation on the Interfering Ability of SK Murine Virus 
It has been reported previously (3) that SK murine virus, following partial 
inactivation by ultraviolet light, had preserved some of its ability to interfere 
with  simian virus.  The  source  of  light  was  a  cold  mercury vapor quartz 
lamp (Lepel), energized by high frequency current, which emitted a spectrum 
in which the longer ultraviolet waves ranging from 2800  to 3100/~mgstr6m 
units predominated.  The same  lamp had  been  used  in  earlier experiments 
(9)  describing  the  inactivation of  simian  poliomyelitis virus.  Exposure  of 
murine virus,  in  form of lightly centrifuged 10  per  cent viral mouse brain 
suspensions, for periods of time varying from 15  to 30 minutes at a  distance 
of about 25 cm. from the lamp, brought about a loss of potency which extended 
from partial inactivation to complete destruction.  In further pursuit of this 
work it was learned that the method of raying and the equipment employed 
were too crude to permit of regular and repeatable results.  Thus, it proved 
difficult or impossible to determine the exact time interval at which partial 
inactivation of the virus proceeded to complete destruction.  Moreover, dif- 
ferent runs, even though carried out under presumably identical experimental 
conditions, failed to yield preparations with uniform degrees of mouse potency. 
When such irradiated preparations were  examined for interference in  rhesus monkeys, 
extremely variable results were obtained.  Thus, in a  group of 3  monkeys receiving intra- 
cerebrally mixtures of irradiated murine virus (0.5  cc.  10  -1) and simian virus (0.5 cc.  1:50 
Aycock strain),  one  monkey  remained free  from  paralytic symptoms  whereas  2  monkeys CLAUS W.  JUNGEBLUT  283 
developed paralysis.  Equally erratic were the results obtained by peripheral administration. 
Thus, in a group of 9 monkeys which were treated with multiple doses of irradiated murine 
virus (36 to 48 cc. of 10 per cent brain suspension intravenously) beginning with the day of 
poliomyelitic infection (0.5 cc. Aycock 1:50 or 0.5 cc. RMV  1:200,  intracerebrally), there 
were  2 non-paralytic survivors whereas  7 animals developed  various degrees  of paralysis. 
All of 17 accompanying control animals succumbed  to the disease.  The few instances of 
successful interference,  in which protection occurred, were obtained with murine virus which 
had only been attenuated (residual mouse potency: 10  -1 i.c.  +;  10  -1 i.p. --) but not fully 
inactivated. 
The above data reflect the inherent difficulties of securing constant results 
with  irradiated murine virus prepared by technically inadequate methods  of 
irradiation.  It  should  be  pointed  out,  however,  that  whatever  interference 
had occurred with irradiated virus of minimum infectivity, in all probability, 
was not caused by the operation of active virus particles.  For virus prepara- 
tions of equivalent  infectivity, which  can  be produced by simple dilution of 
the  infectious  brain  suspension,  are  completely  devoid  of  any  interfering 
power.  In  summary,  the  findings  indicate  that  viability  and  interfering 
power of murine virus are, to some extent, selectively susceptible to inactiva- 
tion by ultraviolet light; but it also becomes apparent  that present methods 
of irradiation, without permitting rigid control over the intensity and length 
of exposure, fall short of accomplishing this objective in a satisfactory manner. 
Interference between MM Murine Poliomyelitis Virus and Simian 
Poliomyelitis Virus 
The  following  section  presents  experiments  in  which  the  murine  strain 
of MM  poliomyelitis virus  was  studied  for  its  ability to  interfere  in  rhesus 
monkeys  with  two  standard  strains  (Aycock, RMV)  of simian poliomyelitis 
virus.  Interference,  in  the  hamster,  between  MM  murine  virus  and  other 
murine  (SK,  Lansing,  Theiler)  or  simian  (RMV,  Ayc0ck)  strains  of polio- 
myelitis virus has already been demonstrated by Dalldorf and Whitney (10). 
Properties of MM Murine Virus.--The isolation of MM poliomyelitis virus from a fatal 
human case and its adaptation, through hamsters, to rodents has previously been described 
in detail (5).  When tested in albino mice, MM routine virus reaches  titers of 10  -I° intra- 
cerebrally and 10  -9 intraperitoneaily, showing considerably more virulence and invasiveness 
than does SK murine virus; it is also highly pathogenic, by both intracerebral and peripheral 
inoculation, for other rodents, including cotton rats, hamsters, and guinea pigs, but is harm- 
less in rabbits.  MM infection  in these rodents is definitely conditioned  by an age factor 
in the host, younger animals being more susceptible by both intracerebrai and peripheral 
injection.  Like SK routine virus,  MM murine virus is readily inactivated in mice by an 
antiserum produced against simian poliomyelitis virus, but MM anti-murine serum has no 
neutralizing effect on simian poliomyelitis virus (Aycock, RMV) in rhesus monkeys.  While 
MM murine virus is intimately related to SK mutine virus, as  determined by cross-neu- 
traiization tests, its immunological position in the poliomyelitis group is appreciably closer 
to Theiler's virus than that occupied by SK routine virus (11).  This relationship is also 284  RODENT  POLIOMYELITIS.  VI 
revealed by cross-protection  tests in guinea pigs.  Thus, guinea pigs which have survived a 
symptomless infection with Theiler's mouse virus, usually exhibit a high degree of resistance 
against subsequent intracerebral reinfection with MM murine virus.  Moreover, MM murine 
virus, like Theiler's mouse virus, produces neither fever nor any other recognizable symptoms 
in rhesus monkeys,  irrespective of the route of injection or dosage employed.  The virus is 
readily cultivable in a medium, consisting of embryonic mouse brain suspended in ox serum 
ultrafiltrate, under conditions  similar to those which were used successfully for the in vitro 
propagation of SK murine virus (2).  Despite prolonged  cultivation in this medium (over 
70 passages)  the virus has suffered no loss of peripheral infectivity, such as was noted with 
SK murine virus.  MM murine virus has also been grown, for over 20 serial passages,  in 
chick embryo tissue suspended in ox serum ultraffltrate and has been carried over five serial 
passages in the fertilized hen's egg.  The titers obtained with mouse tissue are considerably 
higher (10  -1° i.e.,  10  -9 i.p.)  than those obtained with either minced chick tissue (10  -5 i.e.) 
or in embryonated eggs (allantoic fluid: 10-1 to 10  -a i.c.). 
Elimination  of MM Murine Virus from Rhesus Monkeys.--Since  the prime 
requisite for interference between  murine  and  simian strains of poliomyelitis 
virus appears to be the ability of the mouse virus to reach and maintain itself 
for some time in the susceptible nerve cells of the monkey, preliminary tests 
were necessary to determine the rate of survival of MM murine virus in rhesus 
monkeys. 
The following experiment was carried out. 
Two monkeys received, by intracerebral injection, 1 cc. each of a  10 per cent suspension 
of MM viral mouse brain.  For purpose of comparison,  3 other monkeys received similar 
injections of 10 per cent Theiler (GDVII) viral mouse brain.  At various intervals, ranging 
from 24 hours to 1 week, these monkeys were sacrificed and their brains and cords, as well as 
blood and other extraneural tissues, were tested for virus content by intracerebral transfer of 
the respective organ emulsions to groups of mice.  The results are shown in Table V. 
As will be seen from Table V,  MM  murine virus could be recovered at an 
early interval, i.e.  48  hours,  in  large  amounts  from  every  tissue  tested  but 
samples obtained after 1 week contained active virus only in certain portions 
of the central nervous system.  Theiler mouse virus, on the other hand,  was 
not  recoverable beyond  the  earliest interval  tested,  i.e.  24  hours,  and  then 
only sporadically and  in moderate amounts.  By  contrast,  SK murine virus 
survived  in  large  amounts  for  1  week  in  all  tissues  examined.  It  appears 
from these data that  the elimination of MM  murine virus follows a  pattern 
which  would  accord  to  it a  position midway between  SK murine  virus and 
Theiler's  virus  of  mouse  encephalomyelitis.  These  observations,  on  the 
whole,  agree  well  with  the  relative  levels  of  monkey  pathogenicity  of  the 
three viruses involved which  grade  in  the  same  general direction; they  also 
illustrate the  greater affinity for monkey  tissues of the  two  adapted  murine 
strains of poliomyelitis virus, as compared with that of Theiler's virus of spon- 
taneous mouse encephalomyelitis. 
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deal with a  study  of the interference phenomenon  between MM  murine virus 
and  simian  poliomyelitis  virus,  as  determined  by:  (1)  mixture  test,  (2)  pe- 
ripheral administration  of  murine virus before  or  after intracerebral injection 
of simian virus. 
TABLE  V 
Recovery of Murine SK Virus, Murine MM Virus, and Theiler Virus from Various  Tissues of 
Normal Monkeys at Certain Intervals after Intracerebral Injection 
Interval of 
sacrifice 
24 hrs. 
48 hrs. 
96 hrs. 
1  wk. 
2 wk. 
Virus 
SK 
MM 
Theiler 
SK 
MM 
Theiler 
SK 
MM 
Theiler 
SK 
MM 
Theiler 
SK 
MM 
Theiler 
.ey tissues tested for recovery of virus in mice 
Blood 
+++ 
+++ 
--  =  No virus present. 
+  =  Trace  of virus present as indicated by long incubation period and scattered 
survival in mice. 
-4--4- =  Intermediate incubation period without survival (moderate amounts of virus). 
-4-++  =  Short incubation period without survival (large amounts of virus). 
In the first group of experiments, MM murine virus (mouse passage virus or tissue culture 
virus propagated on embryonic mouse or chick tissue suspended in ox serum ultrafiltrate) 
was combined in vitro with simian poliomyelitis virus (Aycock,  RMV), using a  volume of 
0.5 cc.  virus suspension for each virus.  Immediately after their preparation the mixtures 
were  injected intracerebrally into rhesus  monkeys.  In  order  to  obtain some information 
on the quantitative limits of such interference, various proportions of the competing viruses 
were chosen in setting up these mixtures.  An adequate number of control animals which had 
received only the test dose of simian virus accompanied these experiments. 
Besides testing unmodified murine virus, there were also examined two preparations which 
had previously been exposed to ultrasonic vibrations or to ultraviolet rays.  A brief descrip- 
tion of the two procedures follows: The ultrasound waves were generated by an oscillator, 286  RODENT  POLIO~rYELITIS.  Vl 
operating at 1000 volts and putting out 500 watts, with a piezoelectric quartz crystal ground 
to a frequency of 600 kc.  By interrupting the runs at short intervals the temperature  was 
never allowed to rise above 38°C.  Virus suspensions, in a volume of 3 cc., were placed in 
10 cc. containers and exposed for various lengths of time.  After exposure for as long as 30 
minutes virus suspensions of the order of 10-17 prepared from viral mouse brains, showed no 
appreciable loss of potency (10  -9 i.e., 10  -9 i.p.) whereas virus suspensions  of the order of 10  -8 or 
10  -6 were completely inactivated  within the same period of time.  By contrast,  undiluted 
tissue culture preparations, when exposed for 5, 15, or 30 minutes, suffered a progressive loss 
of potency as compared with the controls (non-exposed virus:  10  -9 i.e., 10  -9 i.p.; exposed 
virus: at 5 minutes 10  -4 i.e. or i.p., at 15 minutes 10  -2 i.e. or i.p., at 30 minutes 10  -2 i.e. or 
i.p.).  The apparatus  employed for these  experiments had been designed and previously 
used by Stumpf and Green (12) in the disintegration  of Proteus  vulgaris.  We are greatly 
indebted to these two investigators for their assistance with our work.  The ultraviolet lamp 
employed and the procedures involved for raying are carefully described in a publication of 
McKinstry and Reading (13) on the preparation  of an ultraviolet-inactivated  murine (SK) 
poliomyelitis virus vaccine.  The lamp employed was a  H-3, 85 watt mercury arc  lamp, 
fitted with a quartz lens and a Coming light filter which reduced the output to 18 microamperes 
at 1½ inches distance from the lens.  The virus suspension was contained in a cylindrical 
quartz tube which was rotated  at high speed so as to permit exposure of a thin film to the 
action of the rays.  A sample of irradiated  MM 10 per cent viral mouse brain suspension 
was received from Dr. McKinstry to whom we express our sincere gratitude.  The material 
produced no symptoms in mice upon intracerebral injection of 0.03 cc. and may therefore be 
presumed to have been fully inactivated. 
The results will be found in Table VI. 
It can be seen from Table VI that MM  murine virus, in doses of 0.5  cc. 
of  10  -1  and  10-  2,  interfered  effectively with  0.5  cc.  of  10-1  Aycock  simian 
virus but that smaller doses of murine virus, i.e. 0.5 cc. of 10-  3 and 10  -4, failed 
to protect.  When tested against RMV simian virus, protection against the 
largest dose of monkey virus used, i.e.  0.5 cc.  10-1,  was obtained with 0.5 cc. 
of 10-1 MM mouse passage virus but not with tissue culture virus; however, 
two  types  of  tissue  culture  virus  preparations  interfered  effectively  with 
smaller doses of RMV virus; i.e., 0.5 co. 10  -2.  A similar degree of interference 
against RMV virus was observed with MM  mouse passage virus which had 
been exposed  to  ultrasonic vibrations or  to  ultraviolet light; the  irradiated 
preparation  also  protected  against  the  largest  dose  of  Aycock  virus  used; 
i.e.,  0.5  cc.  10-1.  All control animals accompanying these  tests  developed 
prostrating paralysis. 
The results can be summarized by stating that MM  murine poliomyelitis 
virus  interfered  effectively  with  two  strains  of  simian  poliomyelitis virus 
(Aycock, RMV), that this interference seemed to proceed on a definite quantita- 
tive basis, and that among the various preparations tested the most marked 
protection occurred with unmodified mouse passage virus.  It should further 
be noted that for the first time in our experience a preparation of MM murine 
virus, which had been fully  inactivated by exposure to ultraviolet irradiation, 
was capable of inducing protection in monkeys against infection with simian 
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In  the  next  set  of  experiments  MM  murine  virus  was  examined  for  its 
ability  to  protect  rhesus  monkeys  when  administered  peripherally,  prior  to 
TABLE VI 
Interference between MM  Murine  Virus  (Unmodified and Modified by Physical Agencies)  and 
Simian  Virus 
Intracerebral injection of virus mixtures 
No. 
Result 
Murine virus (/viM) 
Preparation 
Mouse brain virus 
tt  ~  ~t 
tc  ~t  ~t 
Tissue  culture  virus 
(embryonic  mouse 
brain) 
Tissue  culture  virus 
(embryonic  chick 
tissue) 
Mouse brain virus 
(ultrasonic vibrated)* 
gl  tl 
Mouse brain virus 
(ultraviolet rayed):~ 
Controls,,,,  ] 
of  ysls  ysis 
Simian virus  mon-  No 
Paral-  keys  •  paral- 
Dose  Strain  Dose 
0.5 cc. i0  -~  Aycock  0.5 cc. 1 : 10  3  0  3 
0.5cc.  10  -~  "  "  "  "  1  0  1 
0.5cc.  10-  a  "  "  "  "  1  1  0 
0.5cc.  10  -4  "  "  "  "  1  1  0 
0.5 cc. 10  -~  RMV  "  "  "  i  0  1 
0.5 cc. undiluted  RMV  0.5 cc.  1 : 10  1  1  0 
0.5 cc. 10-  x 
t~  t~  ~c 
0.5 cc. 10-  l 
"  0.5 cc.  1:100  1  0  I  1 
1  0  1 
RMV  0.5 cc.  1 : 10  I  1  0 
"  0.5 cc.  1:50  1  0  1 
"  0.5 cc.  1:100  1  0  1 
RMV  0.5 cc.  1 : 10  1  1  0 
"  0.5 cc.  1 : 100  1  0  1 
Aycock  0.5 cc.  1 : 10  1  0  1 
Aycock  0.5 cc.  1 : 10  3  3  0 
RMV  ......  i2  2  0 
0.5 cc.  1:100  4  4  0 
* This preparation titered 10  -9, intracerebrally, and 10  -9 intraperitoneally in mice. 
:~ This preparation, injected intracerebrally, produced no symptoms in mice. 
intracerebral  infection  with  simian  virus  (Aycock,  RMV).  In  view  of  its 
comparatively  rapid  rate  ~  elimination,  the  injections  of murine  virus  were 
resumed  after  poliomyelitic  infection.  Unmodified  MM  mouse  virus  or 
mouse-embryonic  tissue  culture  virus  were  used  in  these  tests.  The  experi- 
ments  were  controlled  by  the  inclusion  of untreated  monkeys  receiving only 
the test dose of simian virus.  The results are shown in Table VII. 288  RODENT  POLIOMYELITIS.  VI 
In so far as any conclusions can be drawn from the smaU number of animals 
involved, it would seem that MM  murine mouse virus exerted only a  slight 
protective  action  against  infection  with  simian  virus,  preventing  paralysis 
in 2 of 5 monkeys; no such action was observed with MM murine tissue culture 
virus  under  the  conditions  of  the  experiment.  Further  work  is therefore 
necessary to determine whether  more effective interference can be  obtained 
by adjusting the experimental procedures through choice of a  different route 
of  injection,  prolonged  administration,  or  increased dosage of murine virus. 
TABLE  VII 
Interference  between MM Murine  Virus and Simian Virus in Experiments to  Prevent Infections 
1~o. 
of 
mon- 
keys 
3 
2 
2 
Preparation 
Mouse  brain 
virus 
Tissue culture 
virus  (em- 
bryonic 
mouse brain 
Controls 
Mode of attempt to prevent infection 
(last dose of murine virus given 
1 day before infection) 
No. of injections  of 
murine virus 
(intravenous) 
3 injections  before infec- 
tion  and  3  injections 
after infection 
3 injections  before infec- 
fection and 8-9  injec- 
tions after infection 
3 injections  before infec- 
tion and 5-6 injections 
after infection 
Total 
dosage 
10 per 
cent 
brain 
suspen- 
slon 
cc. 
36 
94-104 
138-158 
Strain 
Aycock 
RMV 
et 
Aycock i 
RMV 
Infection with monkey virus 
Dose 
(intra- 
cerebral) 
0.5 cc.  1:50 
0.5 cc.  1:100 
0.5 cc.  1:50 
0.5 cc.  1:100 
Result 
Com-  plete  Partial  No 
paral-  paral-  )aral- 
ysis  ysis  ysis 
1"  1  1 
1  0  1 
2  0  0 
3  0  0 
3  0  0 
* The incubation period of this animal was unusually long; i.e., 19 days. 
The last group of experiments deals with attempts to abort the development 
of paralysis in rhesus monkeys which received unmodified murine virus (mouse 
passage virus or tissue culture virus propagated on mouse or chick embryonic 
tissue) by peripheral administration, after intracerebral infection with simian 
virus  (RMV,  Aycock).  In  some animals,  treatment  was  begun  on the day 
of infection, in others not until 48 hours had  elapsed.  In all cases,  the ad- 
ministration of murine virus was maintained over a series of multiple injections 
for  approximately  2  weeks.  All  other  details  c~cerning  treated  and  un- 
treated  control  animals  can  be  gathered  from  Table  VIII  which  lists  the 
results obtained. 
It will  be noted from Table VIII that MM  murine virus  (mouse passage 
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all animals treated on the 1st day of the disease.  Thus, of a total of 11 mon- 
keys  so  treated  8  remained  free from  any  signs  of paralysis.  The  results 
obtained with treatment delayed for 48 hours after the inoculation were not 
as striking.  However, while none of 6 animals so treated escaped some para- 
TABLE  VIII 
Interference between MM Murine Virus and Simian  Virus in Attempts #o Modify the Infectious 
Process 
~t~o. 
of 
mon- 
keys 
Preparation 
Mouse brain virus 
!  (10 per cent sus- 
pension) 
Tissue  culture 
virus  (embry- 
!  onic mouse brain 
(undiluted fluid) 
Tissue  culture 
virus  (embry- 
I  onic  chick  tis- 
[  sue)  (undiluted 
:  fluid)  ! 
r  Co :ro  
[ 
J 
Mode of attempt to modify the disease  Infection with monkey virus 
i  i 
No.  of injections  I  i Total  of murine virus  I 
(intravenous)  [  d°~ge i 
-i  -- 
[  ¢¢' 
6  injections  for  72 
first3 days; there- 
after  injections 
continued on al- 
ternatingdays 
"  "  i122-13( 
"  "  88-103  48hr. 
6  injections  for  i168-200  No  inter- 
first 3 days; there- 
)  after injections 
continued on al- 
ternating days 
145-18.5  48 hr.  ~'  "  " 
153-183  No  inter-  RMV  0.5 ee 
val  1:100 
Result 
Interval  Dose 
between  (intra-]  Corn-  Par-  i  No  infection  Strain  eere-  plete  tial  '  par- 
and  bral  paraly-[  aly-  therapy  paraly- 
sis  SlS  i  SIS 
i 
No  inter-  ! Aycoek  0..5 cc.  0  i 
val  1:I0 
l 
i 
I 
"  "  RMV  0.5 cc.  0  [ 
1:100  [ 
l  , 
RMV  0.5 cc. I  1  ] 
val  1:100  i 
i 
1 
1  1  1  6 injections for 
first  3  days; 
thereafter injec- 
tions  continued 
on  alternating 
days 
--  ~  Aycock  0,5  cc.  1  1  0 
--  --  RMV  0.5  co.  ~  3  0  0 
1:10 
:  i 
1:100 
lyric involvement, only 2 monkeys died with prostrating paralysis; the remaining 
4  monkeys showed transitory isolated pareses of the extremities from which 
there was complete recovery in the course of the next 2 or 3  weeks.  All of 
the  5  untreated  control  animals  developed paralysis,  4  prostrating  and  1 
partial.  The over-all statistics, therefore, stand at a morbidity rate of about 
50 per cent and a  mortality rate of about 20 per cent for 17 treated animals 
as compared with a  100 per cent morbidity rate and an 80 per cent mortality 
rate for 5  untreated  controls.  The unusually favorable results  obtained  in 290  REtDENT  POLIOMYELITIS.  VI 
this  series  are probably due  to  several reasons.  In  the  light  of earlier  ex- 
perience, however, it seems likely that adequacy of dosage and maintenance 
of treatment were among the most important contributory factors. 
As one proceeds to compare the two murine strains, SK and MM, for their 
respective interfering  power  against  simian  virus  in  rhesus  monkeys,  there 
is a  suggestion that SK virus acts better to avert infection than MM virus, 
while in attempts to modify the disease MM  virus is  at least as good and, 
TABLE IX 
Interference between Theiler's Virus and Simian Poliomyelitis Virus in Experiments to Prevent 
or Modify Infection 
Experiment 
Intracerebral injection of 
virus mixtures* 
Peripheral injection of 
Theiler's virus prior to in- 
tracerebral  injection  of 
simian virus$ 
Peripheral injection of 
Theiler's  virus  beginning 
with the first day of intra- 
cerebral injection of simian 
virus§ 
Controls 
No. of ] 
Theiler virus (GDVII) 
Strain 
~/~otlse virus 
Cotton rat virus 
Mouse  virus 
Mouse  V~US 
Monkey virus (Aycock strain) 
Dosage 
(intracerebral) 
Result 
Com-  Par-  I  No 
plete  tim  I par- 
paraly-  paraly- 
sis  sis  I~" 
0.5 cc,  1:I0  0 
0.5 cc,  1:50  6 
0.5 cc,  1:10  1 
0.5 cc,  1:50  1 
0.5 cc.  1:50  4 
0.5 cc.  1:50  3 
0.5 cc. 1:50  4 
0  2 
0  1 
0  1 
0  1 
0  2 
0  0 
1  0 
* Details of technique were the same as given m Table VI. 
Details of technique were the same as given in Table VII. 
§ Details of technique were the same as given in Table VIII. 
perhaps,  slightly  more  efficacious than  SK virus.  This  difference could  be 
readily  explained  by  corresponding  differences  in  the  potency  and  rate  of 
elimination of the two strains of virus. 
Interference  between  Theiler's  Virus  of Mouse  Encephalomyelitis  and  Simian 
Poliomyelitis Virus in Rhesus Monkeys 
In  the  following  experiment  Theiler's  virus  of  mouse  encephalomyelitis 
was examined for interference in rhesus monkeys against simian poliomyelitis 
virus  as  determined  by  (a)  mixture  test,  (b)  peripheral  administration  to 
prevent  infection  or  to  modify its  effects.  The  strain  used  was  either  the CLAUS  W.  JUNGEBLUT  291 
standard GDVII mouse virus, originally received from Dr.  Max Theiler, or 
a cotton rat variant of this strain, produced in this laboratory (4).  Antigeni- 
cally, the  two strains were  indistinguishable, but  they differed markedly in 
pathogenicity, the  mouse strain  having  only limited peripheral  potency as 
compared with the highly invasive cotton rat variant (14).  The simian virus 
used was the Aycock strain.  The technical procedures in running these tests 
were,  in  every respect,  similar  to  those  employed in  previous  interference 
experiments  with  the  mouse-adapted  SK  and  MM  strains  of poliomyelitis 
virus.  Table IX lists, in combined form, the results obtained. 
It appears from Table IX that Theiler's virus produced, on occasion, slight 
interference  when  tested  in  mixture  with  simian  virus.  Such  interference 
occurred somewhat more often with the cotton rat variant (2  of 4  monkeys 
escaped paralysis) than with the parent mouse strain (3 of 9 monkeys escaped 
paralysis).  When the mouse strain was tested by peripheral administration 
prior to infection or after it,  the resulting protection seemed even less  since 
in a  combined group  of 9  animals so treated only 2  escaped paralysis.  All 
of  5  control animals developed  paralysis.  Attempts  to  use  the  cotton  rat 
variant  in  large  and  repeated  intravenous  doses  for  effective  interference 
had  to  be  abandoned  since  this  virus  under  such  conditions  occasionally 
induced encephalitis or paralysis in rhesus  monkeys.  In  conclusion, it  can 
be said that Theiler's virus of mouse encephalomyelitis was capable of inter- 
fering with simian virus in rhesus monkeys to a low grade extent, but that such 
interference was much inferior to that obtainable with either of the two mouse- 
adapted strains of poliomyelitis virus (SK, MM). 
DISCUSSION 
Since  the  discovery--first with plant  viruses  (15)  and subsequently with 
animal viruses  (16)--that  the  presence  of one viral agent in the  field may 
prove antagonistic to the propagation of another, the "phenomenon of viral 
interference" has been widely studied in recent years.  Examples of certain 
viruses that form interference systems with other viruses, include the infectious 
agents of yellow fever  (17),  lymphocytic choriomeningitis (18),  poliomyelitis 
(1, 2, 3), bacteriophagy (19), influenza (20), and equine encephalomyelitis (21). 
In some instances, one of the viruses is a variant, in others the opposing agents 
are  related  at  least functionally, even  though they may differ in  antigenic 
structure.  All observations agree on one point, namely that the protective 
effects originate under conditions distinct from those that surround the ordinary 
processes  of immunity.  Thus, protection by interference is  immediate but 
evanescent, occurring at a  time when antibodies have not yet developed and 
yielding with  their formation.  Since  no  humoral action  takes  part  in  the 
phenomenon,  it  is  easy  to  understand  that  the  protection  transcends  im- 
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depends upon some direct interchange  between the interfering virus and  the 
susceptible  cell  which  renders  the  latter  refractory  to  subsequent viral  in- 
fection.  Whether such interchange occurs on the outside or inside of the cell, 
whether it involves a mechanical loss of receptors or a metabolic blockade of 
cellular enzyme systems must remain speculative at this time. 
Although  the precise operating  conditions may differ somewhat with  the 
various  known  interference  systems,  the  factors  that  govern  interference 
between murine  and  simian  strains  of poliomyelitis virus may prove to  be 
fairly typical of viral interference in general.  These factors are the following: 
(1)  The  phenomenon  is  quantitative  in  that  definite  proportions  obtain 
between the opposing agents.  (2)  Effective interference requires inordinately 
large amounts of the interfering virus, far in excess of what would suffice for 
specific  immunization.  (3)  Protection  is  considerably  enhanced  by  main- 
tained administration  of the interfering  agent.  These three features,  taken 
together, suggest strongly that the interference reaction is of inanimate (chemi- 
cal)  rather  than  animate  (biological)  nature.  In  fact,  the  entire  process 
bears a close similarity to the phenomenon of "chemotherapeutic interference," 
first described by Browning and  Gulbransen  (22)  and  later  confirmed  and 
extended by Schnitzer  and  his  coworkers (23).  In  the latter  case,  a  given 
trypanocidal  agent  (parafuchsin),  when  present  in  subeffective amounts  in 
an  infected animal,  will  nullify the  curative action  of another  trypanocidal 
agent  (trypaflavin,  arsenicals,  or  antimony  compounds)  subsequently ad- 
ministered,  lust  as  chemotherapeutic  interference  can  be  elicited  only at 
certain  intervals  and  with certain  amounts  of the competing substances, so 
is viral interference conditioned by dosage and  time of administration  of the 
interfering viruses. 
Notwithstanding  these  considerations,  the  experimental  data  presented 
in this paper offer no clear-cut indication  that  the principle in murine virus 
which interferes with simian  virus in rhesus monkeys can be dissociated from 
the infectious unit.  On the contrary, much of the evidence could be inter- 
preted to show that there is but a single entity.  Thus, processes of physical 
~segregation  fail  to  liberate  from  the  virus  particle  an  interfering  principle 
which  might  conceivably have  existed  as  a  soluble  substance  in  the  viral 
material.  Moreover, exposure of the virus to certain crude inactivating agen- 
cies affects pathogenicity and interfer~g capacity in the same sense.  Other 
observations, however,  can  be cited  which  are  not  in  agreement  with  the 
deduction that reproductive and interfering power are identical.  For instance, 
some undiluted virus preparations which had been severely injured in potency 
(reduction of mouse titer from 10  -9 to 10  -1) by chemical  (formalin),  physical 
(ultraviolet irradiation),  or immunological  (antiserum)  action,  still possessed 
definite interfering  ability in rhesus monkeys.  By contrast, active virus sus- 
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dilution,  have  no  interfering power  whatsoever.  It  would  seem  therefore 
as  if interference,  in  its  quantitative  aspects,  depends  less  upon  a  critical 
concentration of multiplying virus particles than upon a critical concentration 
of some non-multiplying neurotropic factor, present in undiluted viral material, 
which will not tolerate much dilution.  In other words,  the question arises 
whether or not there are present in the particle of murine virus two different 
functions or  groups:  one  infectious, highly specialized,  and  concerned with 
virus propagation in mice but not in monkeys, the other non-infectious, less 
specialized, and concerned with virus transport to the susceptible nerve cells 
of both  monkeys and  mice--implying that  the  latter  function or  group  is 
responsible  for  interference.  A  further  elucidation  of  this  point  is  one  of 
the most pressing problems in this field. 
CONCLUSIONS 
1.  Attempts  to  separate  by processes  of physical segregation,  i.e.  ultra- 
filtration, ultracentrifugation, or dialysis, from live SK murine poliomyelitis 
virus a non-pathogenic agent capable of interfering with simian poliomyelitis 
virus were unsuccessful.  Neither was it possible to convert live SK murine 
virus into a non-pathogenic interfering agent by processes of chemical inactiva- 
tion, i.e., phenolization or formalinization. 
2.  Preparations of SK murine virus, which had been markedly attenuated 
by ultraviolet irradiation, gave evidence of having retained some interfering 
power in rhesus monkeys. 
3.  MM murine poliomyelitis virus interfered, both in mixture tests and by 
peripheral  administration,  with  two  simian  strains  of  poliomyelitis virus. 
With adequate amounts, distinct protective effects could be obtained in rhesus 
monkeys which had received murine virus  (animal passage or tissue culture 
virus)  up  to 48 hours after intracerebral infection with simian poliomyelitis 
virus. 
4.  Theiler's virus of spontaneous mouse encephalomyelitis, when tested in 
mixture with simian poliomyelitis virus, gave some evidence of irregular and 
low  grade  interference.  Interference  could  not  be  shown  conclusively in 
experiments to prevent poliomyelitic infection or to modify its effects. 
5.  The nature of the interfering agent present in murine virus is discussed. 
The author wishes to express his gratitude to Mr.  Frank Vasi for his assistance in this 
investigation. 
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